'Ideal biomarker' detects Alzheimer's disease before the onset of symptoms
A new biomarker detects Alzheimer's disease in its preclinical phase, identifying individuals with impaired neuropsychological and neurophysiological functions. The discovery has high accuracy and sensitivity, offering a promising approach to early diagnosis and treatment.
SourceAgency for evolving and promotion of STEM disciplines·JournalHuman Brain Mapping·DateOct 3, 2017